跳至主要内容
临床试验/KCT0003970
KCT0003970招募中未知

Aspirin and a PoTent P2Y12 Inhibitor versus Aspirin and Clopidogrel Therapy in Patients Undergoing Elective Percutaneous Coronary Intervention for Complex Lesion Treatment

Samsung Medical Center0 个研究点目标入组 3,500 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
3,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1 a patient over the age of nineteen
  • 2 Those who fully understand the risks and benefits of participating in the study and who have prior consent;
  • 3 Unstable angina patient
  • 4 Patients who are scheduled or have already received percutaneous coronary artery intervention due to coronary complex lesions
  • ? Coronary artery complex lesions are defined as those that are accompanied by one or more of the following nine.
  • 1) Medina branch lesions (1,1/1,1,0,1,1) with lateral branch sizes greater than 2.5 mm
  • 2) Target vessels are chronic complete pulmonary lesions (=3 months)
  • 3) If it is an unprotected left-wedge lesion (the left-wedge basin lesion also includes a non-vigilant basin lesion).)
  • 4) The inserted stent is a long lesion with a length of 38mm or more.
  • 5) If a coronary artery intervention is performed in two or more major coronary arteries at a time due to a multivascular disease.
  • 6) If multiple stents are required (£3 more stent per patient)
  • 7) In case of coronary stent re-stenosis lesion
  • 8) Serious coronary calcification lesions (encircling calcium in angiography)
  • 9) In case of left - hand, left - hand, and right - hand coronary artery entrance lesions

排除标准

  • 1 In case of hemodynamically unstable or psychotropic shock.
  • 2 Serious bleeding (brain bleeding, gastrointestinal bleeding, hematuria, haemostasis, etc.)
  • 3 In the past, there has been a cerebral hemorrhage, a routine ischemia, or a stroke.
  • 4 Sensitive to contrast agents or research drugs (aspirin, prasugrel, clopidogrel)
  • 5 Pregnant or pregnant woman with pregnancy plans during the research period
  • 6 Expected life is less than a year or research protocol cannot be followed due to a shared disease other than the heart;
  • 7 Biomarker positive ACS
  • 8 Patients taking prasugrel or ticagrel with ACS within 1 year
  • 9 If you are older than 75 or weigh less than 60kg

研究者

相似试验